ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	25/147	191/7206	5.52415818891e-14
ko05164	Influenza A	20/147	167/7206	1.19859210539e-10
ko04621	NOD-like receptor signaling pathway	17/147	157/7206	1.55038697013e-08
ko04672	Intestinal immune network for IgA production	9/147	37/7206	3.66117697597e-08
ko04064	NF-kappa B signaling pathway	13/147	96/7206	5.87023195605e-08
ko05152	Tuberculosis	17/147	187/7206	2.08520427636e-07
ko05145	Toxoplasmosis	14/147	126/7206	2.25435043591e-07
ko04380	Osteoclast differentiation	14/147	134/7206	4.86026212919e-07
ko05162	Measles	13/147	120/7206	8.37031484468e-07
ko05340	Primary immunodeficiency	7/147	30/7206	1.75086520556e-06
ko04217	Necroptosis	15/147	178/7206	2.96425682762e-06
ko04612	Antigen processing and presentation	10/147	77/7206	3.13125384824e-06
ko04658	Th1 and Th2 cell differentiation	11/147	96/7206	3.49136587495e-06
ko04650	Natural killer cell mediated cytotoxicity	11/147	97/7206	3.86976724152e-06
ko05168	Herpes simplex infection	15/147	182/7206	3.91060211278e-06
ko04668	TNF signaling pathway	12/147	120/7206	5.27159467465e-06
ko05330	Allograft rejection	6/147	24/7206	6.46751238858e-06
ko04660	T cell receptor signaling pathway	12/147	124/7206	7.42461513698e-06
ko05161	Hepatitis B	14/147	173/7206	1.0330812656e-05
ko05323	Rheumatoid arthritis	10/147	89/7206	1.17776907166e-05
ko04630	Jak-STAT signaling pathway	12/147	132/7206	1.41467388825e-05
ko05321	Inflammatory bowel disease (IBD)	8/147	56/7206	1.53783220184e-05
ko05320	Autoimmune thyroid disease	6/147	29/7206	2.09817318446e-05
ko04620	Toll-like receptor signaling pathway	10/147	100/7206	3.31088622226e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	13/147	191/7206	0.000131351342185
ko05140	Leishmaniasis	8/147	75/7206	0.000131731588379
ko04062	Chemokine signaling pathway	13/147	201/7206	0.000218663601259
ko04622	RIG-I-like receptor signaling pathway	7/147	62/7206	0.000245118858167
ko05160	Hepatitis C	11/147	153/7206	0.000273147896521
ko04659	Th17 cell differentiation	9/147	106/7206	0.00029232325578
ko05310	Asthma	4/147	17/7206	0.000321715117624
ko05332	Graft-versus-host disease	4/147	18/7206	0.000407112358452
ko03050	Proteasome	6/147	54/7206	0.000750051072377
ko05416	Viral myocarditis	6/147	55/7206	0.000827943623176
ko04210	Apoptosis	11/147	180/7206	0.00107932827876
ko04623	Cytosolic DNA-sensing pathway	5/147	41/7206	0.00136855784285
ko00051	Fructose and mannose metabolism	5/147	42/7206	0.00152833033589
ko05133	Pertussis	7/147	87/7206	0.00190661566042
ko05144	Malaria	5/147	45/7206	0.00209016693542
ko05166	HTLV-I infection	14/147	292/7206	0.00244929556405
ko04940	Type I diabetes mellitus	4/147	32/7206	0.00383384526547
ko04610	Complement and coagulation cascades	6/147	79/7206	0.00532458683132
ko05150	Staphylococcus aureus infection	4/147	36/7206	0.00589718539161
ko04917	Prolactin signaling pathway	6/147	87/7206	0.00847368131234
ko05146	Amoebiasis	6/147	99/7206	0.0154271214319
ko05142	Chagas disease (American trypanosomiasis)	7/147	130/7206	0.0167371539469
ko04514	Cell adhesion molecules (CAMs)	7/147	130/7206	0.0167371539469
ko04145	Phagosome	8/147	162/7206	0.0174983700239
ko05215	Prostate cancer	6/147	111/7206	0.0256007340384
ko04657	IL-17 signaling pathway	5/147	87/7206	0.0320866927099
ko04662	B cell receptor signaling pathway	5/147	88/7206	0.0334807897937
ko05120	Epithelial cell signaling in Helicobacter pylori infection	5/147	92/7206	0.0394316426995
ko04640	Hematopoietic cell lineage	4/147	64/7206	0.0411492812522